Allelic Variants
|
There are no related allelic variants
|
|
Number of involved diseases in the family |
134 |
Number of CDKL2 related diseases |
0 |
All kinase in this family
CDKL2
Allelic Variants |
Disease Description |
Involved kinases (This family) |
Inhibitor of Involved Kinases |
Search Disease |
n/a | Epstein-Barr virus infection | CDC2, CDK2, FGR, JAK1, JAK3, LYN, MAP3K7, MAPK14, PRKACA, RIPK1, SYK, TYK2 | 20 | Link | n/a | Measles | CDK2, FYN, IRAK4, JAK1, JAK2, JAK3, MAP3K7, PRKCQ, TYK2 | 34 | Link | | Prostate cancer | CDK2, EPHB2, FGFR1, FGFR2, IGF1R, INSRR, MAP2K1, PDGFRA, PDGFRB | 18 | Link | n/a | Tuberculosis | IRAK4, JAK1, JAK2, MAPK14, PLK3, SRC, SYK | 28 | Link | | Leukemia | ABL1, ABL2, JAK2, KIT, MAP2K1, PDGFRB, TGFBR1 | 17 | Link | n/a | Toxoplasmosis | IRAK4, JAK1, JAK2, MAP3K7, MAPK14, TYK2 | 16 | Link | n/a | Herpes simplex infection | CDC2, CDK2, JAK1, JAK2, MAP3K7, TYK2 | 25 | Link | n/a | Influenza A | IRAK4, JAK1, JAK2, MAP2K1, MAPK14, TYK2 | 16 | Link | | Melanoma | FGFR1, IGF1R, MAP2K1, MET, PDGFRA, PDGFRB | 7 | Link | n/a | Epithelial cell signaling in Helicobacter pylori infection | CSK, LYN, MAPK14, MET, SRC | 15 | Link | n/a | Leishmaniasis | IRAK4, JAK1, JAK2, MAP3K7, MAPK14 | 16 | Link | n/a | Hepatitis C | JAK1, MAPK14, RIPK1, TYK2 | 4 | Link | | Neuroblastoma | ALK, NTRK1, NTRK2, NTRK3 | 5 | Link | n/a | Shigellosis | ABL1, MAPK14, SRC | 17 | Link | n/a | Cardiomyopathy | PRKAA1, PRKAA2, PRKACA | 3 | Link | n/a | Chagas disease | IRAK4, MAPK14, TGFBR1 | 3 | Link | n/a | Alcoholism | MAP2K1, NTRK2, PRKACA | 4 | Link | n/a | Salmonella infection | MAPK14, PKN1, PKN2 | 4 | Link | n/a | Viral myocarditis | ABL1, ABL2, FYN | 5 | Link | n/a | Prion diseases | FYN, MAP2K1, PRKACA | 3 | Link | | Lung cancer | ALK, CDK2, ROS1 | 14 | Link | | Gastrointestinal stromal tumor | KIT, PDGFRA | 3 | Link | | Pfeiffer syndrome | FGFR1, FGFR2 | 2 | Link | | Jackson-Weiss syndrome | FGFR1, FGFR2 | 2 | Link | | Hemangioma | FLT4, KDR | 7 | Link | | SCID | JAK3, LCK | 9 | Link | n/a | Immunodeficiencies | JAK3, LCK | 9 | Link | | LADD syndrome | FGFR2, FGFR3 | 2 | Link | n/a | Pertussis | IRAK4, MAPK14 | 3 | Link | | Diabetes mellitus | INSR, PRKCD | 16 | Link | | Crouzon syndrome | FGFR2, FGFR3 | 2 | Link | n/a | Myeloproliferative disorder | JAK2, PDGFRB | 14 | Link | n/a | Pathogenic Escherichia coli infection | ABL1, FYN | 5 | Link | | Gastric cancer | FGFR2, MET | 2 | Link | n/a | Thyroid cancer | NTRK1, RET | 5 | Link | n/a | Medullary thyroid carcinoma | NTRK1, RET | 5 | Link | n/a | Type I diabetes mellitus | ERBB3, PRKCQ | 10 | Link | | Colon cancer | AURKA, SRC | 71 | Link | n/a | Cocaine addiction | CDK5, PRKACA | 2 | Link | n/a | Glioma | PDGFRA, PDGFRB | 2 | Link | | Scaphocephaly | FGFR2 | 2 | Link | | Agammaglobulinemia | BTK | 2 | Link | n/a | Saethre-Chotzen syndrome | FGFR2 | 2 | Link | n/a | Maturity onset diabetes of the young | BLK | 2 | Link | n/a | Agammaglobulinemia and isolated hormone deficiency | BTK | 2 | Link | n/a | Scaphocephaly and Axenfeld-Rieger anomaly | FGFR2 | 2 | Link | n/a | Multiple myeloma | FGFR3 | 2 | Link | n/a | Prader-Willi and Angelman syndromes | CDKL5 | 1 | Link | n/a | Achondroplasia | FGFR3 | 2 | Link | n/a | Cervical cancer | FGFR3 | 2 | Link | | Colorectal cancer | FGFR3 | 2 | Link | n/a | CATSHL syndrome | FGFR3 | 2 | Link | n/a | FGFR3-related short limb skeletal dysplasias | FGFR3 | 2 | Link | n/a | Pituitary Dwarfism | BTK | 2 | Link | n/a | Agammaglobulinemias | BTK | 2 | Link | n/a | Bladder cancer | FGFR3 | 2 | Link | n/a | Chrondrodysplasia | BMPR1B | 1 | Link | | Fibrodysplasia ossificans progressiva | ACVR1 | 2 | Link | n/a | Early infantile epileptic encephalopathy | CDKL5 | 1 | Link | | Kallmann syndrome | FGFR1 | 2 | Link | n/a | Leukoencephalopathy, diffuse hereditary, with spheroids | CSF1R | 2 | Link | n/a | Choriocarcinoma | CSF1R | 2 | Link | n/a | Spondylometaepiphyseal dysplasia | DDR2 | 2 | Link | n/a | Hypochondroplasia | FGFR3 | 2 | Link | n/a | Lethal congenital contractural syndrome | ERBB3 | 1 | Link | | Osteoglophonic dysplasia | FGFR1 | 2 | Link | | Trigonocephaly | FGFR1 | 2 | Link | | Brachydactyly | BMPR1B | 1 | Link | n/a | Epileptic encephalopathy | CDKL5 | 1 | Link | | Craniofacial-skeletal-dermatologic dysplasia | FGFR2 | 2 | Link | | Craniosynostosis | FGFR2 | 2 | Link | | Hypogonadotropic hypogonadism | FGFR1 | 2 | Link | n/a | Angelman syndrome-like | CDKL5 | 1 | Link | | Bent bone dysplasia syndrome | FGFR2 | 2 | Link | n/a | Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis | FGFR2 | 2 | Link | | Apert syndrome | FGFR2 | 2 | Link | | Beare-Stevenson cutis gyrata syndrome | FGFR2 | 2 | Link | n/a | Malignant pleural mesothelioma | IGF1R | 7 | Link | n/a | Muenke syndrome | FGFR3 | 2 | Link | n/a | Amoebiasis | PRKACA | 1 | Link | n/a | Renal agenesis and Renal adysplasia | RET | 3 | Link | | Hirschsprung disease | RET | 3 | Link | | Central hypoventilation syndrome | RET | 3 | Link | n/a | Congenital central hypoventilation syndrome | RET | 3 | Link | n/a | Vibrio cholerae infection | PRKACA | 1 | Link | n/a | Hypereosinophilic syndrome | PDGFRA | 2 | Link | | Hepatocellular carcinoma | MET | 2 | Link | n/a | Congenital myasthenic syndrome | MUSK | 2 | Link | n/a | Myasthenic syndrome | MUSK | 2 | Link | n/a | Obesity | NTRK2 | 3 | Link | n/a | Insensitivity to pain | NTRK1 | 5 | Link | | Multiple endocrine neoplasia | RET | 3 | Link | | Pheochromocytoma | RET | 3 | Link | n/a | Rheumatoid arthritis | TEK | 3 | Link | | Loeys-Dietz syndrome | TGFBR1 | 1 | Link | n/a | Familial thoracic aortic aneurysm and dissection | TGFBR1 | 1 | Link | n/a | Tyrosine kinase 2 deficiency | TYK2 | 1 | Link | | Multiple self-healing squamous epithelioma | TGFBR1 | 1 | Link | | Venous malformations | TEK | 3 | Link | n/a | Transient erythroblastopenia of childhood | TEC | 1 | Link | | Renal agenesis | RET | 3 | Link | n/a | Popliteal pterygium syndrome | RIPK4 | 1 | Link | n/a | Non-syndromic X-linked mental retardation | RPS6KA3 | 2 | Link | | Mental retardation | RPS6KA3 | 2 | Link | n/a | Coffin-Lowry syndrome | RPS6KA3 | 2 | Link | n/a | Autism suseptibility | MET | 2 | Link | n/a | Malaria | MET | 2 | Link | | Insulin-like growth factor I | IGF1R | 7 | Link | n/a | Leprechaunism | INSR | 7 | Link | | Rabson-Mendenhall syndrome | INSR | 7 | Link | n/a | Invasive pneumococcal disease | IRAK4 | 1 | Link | | Hyperinsulinemic hypoglycemia | INSR | 7 | Link | n/a | Synovial sarcoma | IGF1R | 7 | Link | n/a | Lymphedema | FLT4 | 2 | Link | n/a | Nevus | FGFR3 | 2 | Link | n/a | Spermatocytic seminoma | FGFR3 | 2 | Link | n/a | Thanatophoric dysplasia | FGFR3 | 2 | Link | n/a | Lymphedemas | FLT4 | 2 | Link | n/a | Cancer progression/metastasis | FGFR4 | 2 | Link | | IRAK4 deficiency | IRAK4 | 1 | Link | | Lymphoproliferative syndrome | ITK | 2 | Link | n/a | Noonan syndrome and related disorders | MAP2K1 | 2 | Link | | Cardiofaciocutaneous syndrome | MAP2K1 | 2 | Link | n/a | Amyotrophic lateral sclerosis | MAPK14 | 2 | Link | n/a | Cholangiocarcinoma | MET | 2 | Link | | Renal cell carcinoma | MET | 2 | Link | | Mastocytosis with associated hematologic disorder | KIT | 3 | Link | | Mast cell leukemia | KIT | 3 | Link | n/a | Budd-Chiari syndrome | JAK2 | 14 | Link | | Polycythemia vera | JAK2 | 14 | Link | | Myelofibrosis | JAK2 | 14 | Link | | Thrombocythemia | JAK2 | 14 | Link | n/a | Germ cell tumors | KIT | 3 | Link | | Piebaldism | KIT | 3 | Link |
|